ADGM (Adagio Medical Holdings) Beginning Cash Position: $17.11 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ADGM Adagio Medical Holdings Inc ADGM
11 GF Score
Price $0.68
! 3 Warning Signs
View Full Analysis

What is Adagio Medical Holdings Beginning Cash Position?

Adagio Medical Holdings ADGM -5.07% 11 Beginning Cash Position is $17.11 Mil as of Mar. 2026. GuruFocus rates ADGM with a GF Score™ of 11/100. The stock has 3 warning signs investors should review.

Adagio Medical Holdings's Beginning Cash Position for the quarter that ended in Mar. 2026 was $17.11 Mil.

Adagio Medical Holdings's quarterly Beginning Cash Position increased from Sep. 2025 ($8.20 Mil) to Dec. 2025 ($20.81 Mil) but then declined from Dec. 2025 ($20.81 Mil) to Mar. 2026 ($17.11 Mil).

Adagio Medical Holdings's annual Beginning Cash Position declined from Dec. 2023 ($5.55 Mil) to Dec. 2024 ($0.00 Mil) but then increased from Dec. 2024 ($0.00 Mil) to Dec. 2025 ($20.59 Mil).

Adagio Medical Holdings Beginning Cash Position Related Terms

Adagio Medical Holdings Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Adagio Medical Holdings's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Adagio Medical Holdings Beginning Cash Position Chart

Adagio Medical Holdings Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Beginning Cash Position
39.23 18.85 5.55 0.00 20.59

Adagio Medical Holdings Quarterly Data
Dec21 Dec22 Mar23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.59 12.96 8.20 20.81 17.11
ADGM
11GF Score
Adagio Medical Holdings Inc ADGM
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Adagio Medical Holdings Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of $17.11 Mil mean?
Adagio Medical Holdings (ADGM) has a Beginning Cash Position of $17.11 Mil as of Mar. 2026. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Adagio Medical Holdings and its competitors.
Is Adagio Medical Holdings' Beginning Cash Position too high?
Adagio Medical Holdings' current Beginning Cash Position is $17.11 Mil. Overall, Adagio Medical Holdings has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Adagio Medical Holdings' Beginning Cash Position compare to NXL and ICCM?
Adagio Medical Holdings' Beginning Cash Position of $17.11 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Medical Devices & Instruments company?
A good Beginning Cash Position depends on the Medical Devices & Instruments industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Adagio Medical Holdings and its competitors. Adagio Medical Holdings's current Beginning Cash Position is $17.11 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Adagio Medical Holdings stock overvalued right now?
Adagio Medical Holdings (ADGM) has a current Beginning Cash Position of $17.11 Mil. The current Beginning Cash Position is $17.11 Mil. Adagio Medical Holdings' overall GF Score™ is 11/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Adagio Medical Holdings (ADGM), the current Beginning Cash Position is $17.11 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Adagio Medical Holdings Business Description

Address 26051 Merit Circle, Suite 102, Laguna Hills, CA, USA, 92653
Adagio Medical Holdings Inc is a medical device company focused on developing and commercializing products for the treatment of cardiac arrhythmias with its proprietary, catheter-based Ultra-Low Temperature Ablation (ULTA) technology. UTLA is designed to create large, durable lesions extending through the depth of both diseased and healthy cardiac tissue. The company is currently focused on the treatment of ventricular tachycardia (VT), a rapid, abnormal heart rhythm, or arrhythmia, that originates in the heart's lower chambers, or ventricles. The company has one reportable segment.
11GF Score

Get the complete analysis for ADGM

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.68
Price